Efficacy of cognitive rehabilitation on psychosocial functioning in Borderline Personality Disorder: a randomized controlled trial
Por:
Pascual, JC, Palomares, N, Ibanez, A, Portella, MJ, Arza, R, Reyes, R, Feliu-Soler, A, Diaz-Marsa, M, Saiz-Ruiz, J, Soler, J, Carrasco, JL
Publicada:
21 oct 2015
Resumen:
Background: Follow-up studies revealed that subjects with borderline personality disorder (BPD) present high rates of clinical remission, although psychosocial functioning often remains impaired. The aim of this study is to evaluate the efficacy of a cognitive rehabilitation intervention versus a psychoeducational program on psychosocial functioning in subjects with BPD.
Methods: A multicenter, randomized, and positive-controlled clinical trial was conducted. Seventy outpatients with BPD were randomized to cognitive rehabilitation or psychoeducational group interventions. Participants were evaluated after completion of the intervention period (16 weeks) and after the follow-up period (6 months). Psychosocial functioning, clinical and neuropsychological outcomes were evaluated.
Results: No main effects of group or group x time were observed on functionality but a significant effect of time was found. Post-hoc analyses showed that only cognitive rehabilitation increased psychosocial functioning significantly at endpoint. Psychoeducation showed a significant enhancement of depressive symptoms.
Conclusions: Cognitive rehabilitation and psychoeducational interventions appeared to show good efficacy in improving disabilities in daily life in subjects with BPD. These interventions are easily implemented in mental health settings and have the advantage of improving general functioning and clinical symptoms.
Filiaciones:
Pascual, JC:
Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain
Univ Autonoma Barcelona, Inst Invest Biomed St Pau IIB St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08025, Spain
Palomares, N:
Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
Univ Complutense, Dept Psiquiatria, Ctr Invest Biomed Red Salud Mental CIBERSAM, E-28040 Madrid, Spain
Ibanez, A:
Univ Hosp Ramon & Cajal, CIBERSAM, IRYCIS, Dept Psychiat, Madrid, Spain
Univ Alcala De Henares, Dept Psychiat, Madrid, Spain
Portella, MJ:
Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain
Univ Autonoma Barcelona, Inst Invest Biomed St Pau IIB St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08025, Spain
Arza, R:
Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
Univ Complutense, Dept Psiquiatria, Ctr Invest Biomed Red Salud Mental CIBERSAM, E-28040 Madrid, Spain
Reyes, R:
Univ Hosp Ramon & Cajal, FIBio HRC, Madrid, Spain
Feliu-Soler, A:
Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain
Univ Autonoma Barcelona, Inst Invest Biomed St Pau IIB St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08025, Spain
Diaz-Marsa, M:
Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
Univ Complutense, Dept Psiquiatria, Ctr Invest Biomed Red Salud Mental CIBERSAM, E-28040 Madrid, Spain
Saiz-Ruiz, J:
Univ Hosp Ramon & Cajal, CIBERSAM, IRYCIS, Dept Psychiat, Madrid, Spain
Univ Alcala De Henares, Dept Psychiat, Madrid, Spain
Soler, J:
Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain
Univ Autonoma Barcelona, Inst Invest Biomed St Pau IIB St Pau, Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08025, Spain
Carrasco, JL:
Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
Univ Complutense, Dept Psiquiatria, Ctr Invest Biomed Red Salud Mental CIBERSAM, E-28040 Madrid, Spain
Gold, Green Published
|